AIDS 2003
News Features
Virus–host interactions
CD4-independent infection of HIV and SIV
Growing in silence
The impact of host genetics on HIV infection and disease progression in the era of highly active antiretroviral therapy
New observations on CD8 cell responses
Role of neutralizing antibodies in HIV infection
Present status of human HIV vaccine development
New antiretroviral drugs and approaches to HIV treatment
Neutralizing antibodies as a potential secondary protective mechanism during chronic SHIV infection in CD8+ T-cell-depleted macaques,
B cell activation in peripheral blood and lymph nodes during HIV infection,
Analysis of the mitochondrial DNA genome in the peripheral blood leukocytes of HIV-infected patients with or without lipoatrophy,
Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication,
Effect of interleukin-2 plus highly active antiretroviral therapy on HIV-1 replication and proviral DNA (COSMIC trial)
SIVmac pathogenesis in rhesus macaques of Chinese and Indian origin compared with primary HIV infections in humans,
Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers
Severity of HIV-associated neuropathy is associated with plasma HIV-1 RNA levels,
Treatment of tuberculosis in HIV infected persons in the era of highly active antiretroviral therapy,
A randomized trial assessing the impact of phenotypic resistance testing on antiretroviral therapy,
Virological suppression at 6 months is related to choice of initial regimen in antiretroviral-naive patients
Efficacy of a twice-daily antiretroviral regimen containing 100 mg ritonavir/400 mg indinavir in HIV-infected patients,
Increase in condom use and decline in HIV and sexually transmitted diseases among female sex workers in Abidjan, Côte d'Ivoire, 1991–1998,
Study of bias in antenatal clinic HIV-1 surveillance data in a high contraceptive prevalence population in sub-Saharan Africa,
Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up,
Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants,
Effects of CCR5-Δ32 and CCR2-64I alleles on HIV-1 disease progression
Herpes simplex virus type 2 infection increases HIV incidence